Janssen Sues Sandoz Over Alzheimer's Drug Patent
In a complaint filed Aug. 13 in the U.S. District Court for the District of Delaware, Janssen Pharmaceutica, Ortho-McNeil-Janssen Pharmaceuticals Inc. and Synaptech Inc. allege that Sandoz's ANDA falls within one or more claims of a patent pertaining to a method of treatment of Alzheimer’s....
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login